Research ArticleNuclear Cardiology
Effect of Myocardial Viability Assessed by Technetium-99m-Sestamibi SPECT and Fluorine-18-FDG PET on Clinical Outcome in Coronary Artery Disease
Juergen vom Dahl, Carsten Altehoefer, Florence H. Sheehan, Petra Buechin, Gernot Schulz, Ernst Ruediger Schwarz, Karl-Christian Koch, Rainer Uebis, Bruno J. Messmer, Udalrich Buell and Peter Hanrath
Journal of Nuclear Medicine May 1997, 38 (5) 742-748;
Juergen vom Dahl
Carsten Altehoefer
Florence H. Sheehan
Petra Buechin
Gernot Schulz
Ernst Ruediger Schwarz
Karl-Christian Koch
Rainer Uebis
Bruno J. Messmer
Udalrich Buell


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Effect of Myocardial Viability Assessed by Technetium-99m-Sestamibi SPECT and Fluorine-18-FDG PET on Clinical Outcome in Coronary Artery Disease
Juergen vom Dahl, Carsten Altehoefer, Florence H. Sheehan, Petra Buechin, Gernot Schulz, Ernst Ruediger Schwarz, Karl-Christian Koch, Rainer Uebis, Bruno J. Messmer, Udalrich Buell, Peter Hanrath
Journal of Nuclear Medicine May 1997, 38 (5) 742-748;
Effect of Myocardial Viability Assessed by Technetium-99m-Sestamibi SPECT and Fluorine-18-FDG PET on Clinical Outcome in Coronary Artery Disease
Juergen vom Dahl, Carsten Altehoefer, Florence H. Sheehan, Petra Buechin, Gernot Schulz, Ernst Ruediger Schwarz, Karl-Christian Koch, Rainer Uebis, Bruno J. Messmer, Udalrich Buell, Peter Hanrath
Journal of Nuclear Medicine May 1997, 38 (5) 742-748;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Revascularization in Patients With Severe Left Ventricular Dysfunction: Is the Assessment of Viability Still Viable?
- 18F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to 18F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial
- Increasing Benefit From Revascularization Is Associated With Increasing Amounts of Myocardial Hibernation: A Substudy of the PARR-2 Trial
- Assessment of Myocardial Viability in Patients with Heart Failure
- Nuclear cardiology: myocardial perfusion imaging with SPECT and PET
- Myocardial Viability Testing and the Effect of Early Intervention in Patients With Advanced Left Ventricular Systolic Dysfunction
- The Extent of Perfusion-F18-Fluorodeoxyglucose Positron Emission Tomography Mismatch Determines Mortality in Medically Treated Patients With Chronic Ischemic Left Ventricular Dysfunction
- Revascularization in Severe Left Ventricular Dysfunction: The Role of Viability Testing
- Electromechanical Properties of Perfusion/Metabolism Mismatch: Comparison of Nonfluoroscopic Electroanatomic Mapping with 18F-FDG PET
- Radionuclide techniques for the assessment of myocardial viability and hibernation
- Myocardial viability inchronic ischemic heart disease: Comparison of contrast-enhanced magnetic resonance imaging with 18F-fluorodeoxyglucose positron emission tomography
- Comparison of Microsphere-Equivalent Blood Flow (15O-Water PET) and Relative Perfusion (99mTc-Tetrofosmin SPECT) in Myocardium Showing Metabolism-Perfusion Mismatch
- Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function
- Electromechanical mapping for determination of myocardial contractility and viability: A comparison with echocardiography, myocardial single-photon emission computed tomography, and positron emission tomography
- Quantitative Analysis of Acute Myocardial Infarct in Rat Hearts with Ischemia-Reperfusion Using a High-Resolution Stationary SPECT System
- Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis
- Cardiac imaging
- Clinical Outcome of Patients with Previous Myocardial Infarction and Left Ventricular Dysfunction Assessed with Myocardial 99mTc-MIBI SPECT and 18F-FDG PET
- No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: A prospective, randomized comparison of patients with suspicion of jeopardized myocardium